Skip to main content
. 2020 Jul 23;10:12322. doi: 10.1038/s41598-020-69082-z

Figure 4.

Figure 4

Comparison of OS in melanoma according to age, gender, and immune infiltration. (a) OS in patients aged < 60 years, (b) OS in patients aged ≥ 60 years, and (c) OS in patients aged < 60 without high immune signaling. (d) OS in patients aged ≥ 60 without high immune signaling. OS, overall survival.